These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30740909)

  • 1. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.
    Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR
    Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
    Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
    Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer.
    Huang TH; Wu ATH; Cheng TS; Lin KT; Lai CJ; Hsieh HW; Chang PM; Wu CW; Huang CF; Chen KY
    J Cell Mol Med; 2019 Dec; 23(12):8184-8195. PubMed ID: 31638335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
    Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
    Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
    Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers.
    Luo Z; Li Y; Zuo M; Liu C; Tian W; Yan D; Wang H; Li D
    Mol Carcinog; 2017 May; 56(5):1438-1448. PubMed ID: 27996162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
    Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
    Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis.
    Guo T; Kong J; Liu Y; Li Z; Xia J; Zhang Y; Zhao S; Li F; Li J; Gu C
    Biochem Biophys Res Commun; 2017 May; 487(1):153-159. PubMed ID: 28400280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
    Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
    J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin induces stemness in ovarian cancer.
    Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
    Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic potential of NANOG: An important cancer induction mediator.
    Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
    J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ye T; Li J; Sun Z; Liu D; Zeng B; Zhao Q; Wang J; Xing HR
    Int J Biol Sci; 2020; 16(3):447-459. PubMed ID: 32015681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer.
    Fang Y; Wang J; Wang G; Zhou C; Wang P; Zhao S; Zhao S; Huang S; Su W; Jiang P; Chang A; Xiang R; Sun P
    Oncotarget; 2017 Apr; 8(16):26702-26717. PubMed ID: 28460458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.